Article
ANKHD1 contributes to the malignant phenotype of triple-negative breast cancer cells.
Cell biology international - 1 Sept 2022
de Almeida Bruna O, de Almeida Larissa C, Costa-Lotufo Leticia V, Machado-Neto João A
Abstract excerpt
Ankyrin repeat and KH domain-containing protein 1, ANKHD1, has been identified as a regulator of signaling pathways and cellular processes of relevance in carcinogenesis. However, the role of ANKHD1 in breast cancer remains unclear. The aim of the present study was to characterize the expression pattern and involvement of ANKHD1 in the malignant phenotype of breast cancer cell lines and to investigate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
